Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

gallium 68 PSMA-11 4Magnetic Resonance Spectroscopy 4carbon-11 acetate 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2zenocutuzumab 1tempol 1talazoparib 1radium Ra 223 dichloride 1pegilodecakin 1motexafin gadolinium 1bicalutamide 1balstilimab 1apalutamide 1TEMPOL-H 1Suspensions 1Standard of Care 1Sodium Acetate 1Proton Pump Inhibitors 1Prednisone 1Prednisolone 1Powders 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid 1MLN 8237 1Hydrocortisone 1Gadolinium 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Prostatic Neoplasms × MLN 8237 × Clear all
NCT03005262 2018-04-04

MLN8237 for a Subject With Adenocarcinoma of the Prostate

The University of Texas Health Science Center at San Antonio

No longer available
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡